The United States Food and Drug Administration (USFDA) has successfully concluded inspection at Unichem Laboratories’ Active Pharmaceutical Ingredients (APIs) manufacturing unit located at Roha from February 17 to 21, 2020.
The inspection was routine cGMP surveillance and successfully concluded without any FDA form 483 issued.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
